vs
Side-by-side financial comparison of INDEPENDENT BANK CORP (INDB) and Stoke Therapeutics, Inc. (STOK). Click either name above to swap in a different company.
INDEPENDENT BANK CORP is the larger business by last-quarter revenue ($212.5M vs $158.6M, roughly 1.3× Stoke Therapeutics, Inc.). Stoke Therapeutics, Inc. runs the higher net margin — 71.2% vs 35.5%, a 35.7% gap on every dollar of revenue. On growth, Stoke Therapeutics, Inc. posted the faster year-over-year revenue change (3661.1% vs 46.9%). Stoke Therapeutics, Inc. produced more free cash flow last quarter ($131.7M vs $75.5M).
Independent Bank is a bank headquartered in Grand Rapids, Michigan. The bank has 62 branches, all of which are in Michigan.
Stoke Therapeutics, Inc. is a clinical-stage biotechnology company developing innovative RNA-targeted therapies for severe rare genetic diseases. Its lead candidates address unmet needs for Dravet syndrome, a rare epilepsy, and other neurological monogenic disorders, serving patients across North America and global markets.
INDB vs STOK — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2025
| Metric | | |
|---|---|---|
| Revenue | $212.5M | $158.6M |
| Net Profit | $75.3M | $112.9M |
| Gross Margin | — | — |
| Operating Margin | — | 70.2% |
| Net Margin | 35.5% | 71.2% |
| Revenue YoY | 46.9% | 3661.1% |
| Net Profit YoY | 50.6% | 528.0% |
| EPS (diluted) | $1.51 | $1.90 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $212.5M | — | ||
| Q3 25 | $203.3M | — | ||
| Q2 25 | $147.5M | — | ||
| Q1 25 | $145.5M | $158.6M | ||
| Q4 24 | $144.7M | $22.6M | ||
| Q3 24 | $141.7M | — | ||
| Q2 24 | $137.9M | — | ||
| Q1 24 | $137.4M | — |
| Q4 25 | $75.3M | — | ||
| Q3 25 | $34.3M | — | ||
| Q2 25 | $51.1M | — | ||
| Q1 25 | $44.4M | $112.9M | ||
| Q4 24 | $50.0M | $-10.5M | ||
| Q3 24 | $42.9M | — | ||
| Q2 24 | $51.3M | — | ||
| Q1 24 | $47.8M | — |
| Q4 25 | — | — | ||
| Q3 25 | 21.8% | — | ||
| Q2 25 | 44.6% | — | ||
| Q1 25 | 39.3% | 70.2% | ||
| Q4 24 | — | -60.4% | ||
| Q3 24 | 39.0% | — | ||
| Q2 24 | 48.1% | — | ||
| Q1 24 | 45.5% | — |
| Q4 25 | 35.5% | — | ||
| Q3 25 | 16.8% | — | ||
| Q2 25 | 34.6% | — | ||
| Q1 25 | 30.5% | 71.2% | ||
| Q4 24 | 34.6% | -46.4% | ||
| Q3 24 | 30.3% | — | ||
| Q2 24 | 37.2% | — | ||
| Q1 24 | 34.8% | — |
| Q4 25 | $1.51 | — | ||
| Q3 25 | $0.69 | — | ||
| Q2 25 | $1.20 | — | ||
| Q1 25 | $1.04 | $1.90 | ||
| Q4 24 | $1.18 | $-0.15 | ||
| Q3 24 | $1.01 | — | ||
| Q2 24 | $1.21 | — | ||
| Q1 24 | $1.12 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $274.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $3.6B | $350.1M |
| Total Assets | $24.9B | $406.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $274.8M | ||
| Q4 24 | — | $128.0M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $3.6B | — | ||
| Q3 25 | $3.5B | — | ||
| Q2 25 | $3.1B | — | ||
| Q1 25 | $3.0B | $350.1M | ||
| Q4 24 | $3.0B | $229.0M | ||
| Q3 24 | $3.0B | — | ||
| Q2 24 | $2.9B | — | ||
| Q1 24 | $2.9B | — |
| Q4 25 | $24.9B | — | ||
| Q3 25 | $25.0B | — | ||
| Q2 25 | $20.0B | — | ||
| Q1 25 | $19.9B | $406.9M | ||
| Q4 24 | $19.4B | $271.6M | ||
| Q3 24 | $19.4B | — | ||
| Q2 24 | $19.4B | — | ||
| Q1 24 | $19.3B | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $78.9M | $131.8M |
| Free Cash FlowOCF − Capex | $75.5M | $131.7M |
| FCF MarginFCF / Revenue | 35.5% | 83.0% |
| Capex IntensityCapex / Revenue | 1.6% | 0.1% |
| Cash ConversionOCF / Net Profit | 1.05× | 1.17× |
| TTM Free Cash FlowTrailing 4 quarters | $239.0M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $78.9M | — | ||
| Q3 25 | $52.2M | — | ||
| Q2 25 | $106.7M | — | ||
| Q1 25 | $13.3M | $131.8M | ||
| Q4 24 | $42.9M | $-23.2M | ||
| Q3 24 | $70.2M | — | ||
| Q2 24 | $65.6M | — | ||
| Q1 24 | $51.1M | — |
| Q4 25 | $75.5M | — | ||
| Q3 25 | $49.7M | — | ||
| Q2 25 | $102.5M | — | ||
| Q1 25 | $11.3M | $131.7M | ||
| Q4 24 | $36.5M | $-23.2M | ||
| Q3 24 | $64.4M | — | ||
| Q2 24 | $61.9M | — | ||
| Q1 24 | $46.7M | — |
| Q4 25 | 35.5% | — | ||
| Q3 25 | 24.4% | — | ||
| Q2 25 | 69.5% | — | ||
| Q1 25 | 7.8% | 83.0% | ||
| Q4 24 | 25.2% | -102.7% | ||
| Q3 24 | 45.4% | — | ||
| Q2 24 | 44.9% | — | ||
| Q1 24 | 34.0% | — |
| Q4 25 | 1.6% | — | ||
| Q3 25 | 1.2% | — | ||
| Q2 25 | 2.9% | — | ||
| Q1 25 | 1.4% | 0.1% | ||
| Q4 24 | 4.4% | 0.2% | ||
| Q3 24 | 4.1% | — | ||
| Q2 24 | 2.7% | — | ||
| Q1 24 | 3.2% | — |
| Q4 25 | 1.05× | — | ||
| Q3 25 | 1.52× | — | ||
| Q2 25 | 2.09× | — | ||
| Q1 25 | 0.30× | 1.17× | ||
| Q4 24 | 0.86× | — | ||
| Q3 24 | 1.64× | — | ||
| Q2 24 | 1.28× | — | ||
| Q1 24 | 1.07× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
